28/05/2026 07:17
|
Medical, Health & Aged Care
TEVIMBRA plus ZIIHERA and chemotherapy demonstrated statistically significant overall survival benefit with an unprecedented seven-month improvement in first-line HER2+ GEA
Oral presentation at...